Effects of Levodopa-Carbidopa Intestinal Gel Compared with Optimized Medical Treatment on Nonmotor Symptoms in Advanced Parkinson’s Disease: INSIGHTS Study

Background. Nonmotor symptoms (NMS) are common in advanced Parkinson’s disease (APD) and reduce health-related quality of life. Objective. The aim of the study was to evaluate levodopa-carbidopa intestinal gel (LCIG) versus optimized medical treatment (OMT) on NMS in APD. Methods. INSIGHTS was a pha...

Full description

Saved in:

Bibliographic Details
Published in:	Parkinson's disease Vol. 2022; no. 1; p. 1216975
Main Authors:	Chung, Sun Ju, Calopa, Matilde, Ceravolo, Maria G., Tambasco, Nicola, Antonini, Angelo, Chaudhuri, K. Ray, Robieson, Weining Z., Sánchez-Soliño, Olga, Zadikoff, Cindy, Jin, Man, Barbato, Luigi M.
Format:	Journal Article
Language:	English
Published:	United States Hindawi 2022 John Wiley & Sons, Inc Wiley
Subjects:	Carbidopa Comparative analysis Dopa Dopamine Drug dosages Dyskinesia FDA approval Health aspects Intestine Levodopa Medical research Medical treatment Medicine, Experimental Movement disorders Neurodegenerative diseases Parkinson's disease Patients Peripheral neuropathy Quality of life Sleep
ISSN:	2090-8083, 2042-0080
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!